Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.

Big Lots, Inc., through its subsidiaries, operates as a broadline closeout retailer in the United States. It offers products under six merchandising categories: Consumables, Home, Furniture, Hardlines, Seasonal and Other.

Infoblox Inc. (NYSE:BLOX): Thomas Robert D (President and CEO) sold 95,000 shares at a price of $27.51.

Cisco Systems, Inc. designs, manufactures and sells Internet Protocol based networking and other products related to the communications and information technology industry and provides services associated with these products and their use.

Facebook Inc operates a social networking website. Millions of people use Facebook everyday to keep up with friends, upload an unlimited number of photos, share links and videos, and learn more about the people they meet.

Financial Engines, Inc is a provider of independent, technology-enabled portfolio management services, investment advice and retirement help to participants in employer-sponsored defined contribution retirement plans, such as 401(k) plans.

Guess (NYSE:GES): Blumenthal Judith (Director) sold 25,944 shares at a price of $30.84.

Guess Inc designs, markets, distribute and licenses a leading lifestyle collection of contemporary apparel and accessories for men, women and children that reflect the American lifestyle and European fashion sensibilities.

Synageva BioPharma Corp. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

Hancock Holding Company (NASDAQ:HBHC): Horne James H (Director) sold 3,000 shares at a price of $28.44.

Impax Laboratories (NASDAQ:IPXL): Burr Robert L (Director) sold 1,500 shares at a price of $18.80.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development.

Who will be the next Apple? What company with what disruptive idea will turn the world of technology upside down? In this series, Benzinga interviewed CEOs of several technology startups that are maki...